David Hallas Acquires 18,181 Shares of ECO Animal Health Group plc (LON:EAH) Stock

ECO Animal Health Group plc (LON:EAH) insider David Hallas acquired 18,181 shares of ECO Animal Health Group stock in a transaction dated Friday, August 30th. The shares were bought at an average cost of GBX 110 ($1.45) per share, for a total transaction of £19,999.10 ($26,297.30).

ECO Animal Health Group Stock Performance

LON:EAH opened at GBX 114.50 ($1.51) on Wednesday. The company has a debt-to-equity ratio of 4.31, a quick ratio of 2.14 and a current ratio of 2.96. ECO Animal Health Group plc has a fifty-two week low of GBX 82.67 ($1.09) and a fifty-two week high of GBX 135 ($1.78). The firm has a market cap of £77.56 million, a PE ratio of 5,725.00 and a beta of -0.05. The business has a 50 day moving average price of GBX 112.09 and a 200-day moving average price of GBX 107.69.

Wall Street Analysts Forecast Growth

Separately, Shore Capital restated a “buy” rating on shares of ECO Animal Health Group in a report on Tuesday, August 27th.

ECO Animal Health Group Company Profile

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.